Artificial Intelligence (AI) is steadily reshaping digital pathology – but not through sudden disruption or autonomous diagnosis. In the U.S. healthcare environment, AI is evolving as a clinically governed, decision-support technology that enhances diagnostic consistency, operational efficiency, and long-term sustainability for pathology laboratories.

In 2026’s complex reimbursement landscape, clean claims are the foundation of sustainable revenue and optimized cash flo...
read more
For U.S. healthcare providers, 2026 represents a genuine inflection point for accounts receivable (AR) – driven by sever...
read more
Healthcare’s digital transformation has reached a regulatory inflection point. As of January 2026, the Centers for Medic...
read more
For U.S. healthcare providers, advancements in AI and data analytics are no longer experimental – they are actively resh...
read more
Medicare clawbacks related to urinary tract infection (UTI) testing are no longer isolated compliance events. As we move...
read more
Revenue cycle leaders questioning the value of outsourced medical billing services should consider the case of recent re...
read more
Late last year, CMS introduced the Transforming Episode Accountability Model (TEAM). It addresses five surgical categori...
read more
As Home Health Agencies (HHAs) move into 2026, the finalized CMS CY 2026 Home Health Prospective Payment System (HH PPS)...
read more
In U.S. healthcare, small process gaps can have big financial consequences. The revenue cycle – from patient registratio...
read more